• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用整体柱色谱法结合病毒过滤法分析过滤行为。

Analysis of filtration behavior using integrated column chromatography followed by virus filtration.

机构信息

Bioprocess Division, Scientific Affairs Group, Asahi Kasei Medical Co., Ltd., Tokyo, Japan.

Bioprocess Division, Department of Technology, Asahi Kasei Medical Co., Ltd., Nobeoka-shi, Miyazaki-ken, Japan.

出版信息

Biotechnol Bioeng. 2021 Sep;118(9):3569-3580. doi: 10.1002/bit.27840. Epub 2021 Jun 8.

DOI:10.1002/bit.27840
PMID:34032276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8453883/
Abstract

We evaluated filtration behavior and virus removal capability for a monoclonal antibodies (mAb) and plasma IgG under constant flow rate directly following flow-through column chromatography in an integrated process. mAb solution with quantified host cell protein (HCP) content processed in flow-through mode on in-series mixed-mode AEX and modified CEX columns connected to the Planova BioEX filter (pool-less) achieved HCP logarithmic reduction value (LRV) of 2.3 and 93.9% protein recovery, demonstrating comparable or higher HCP LRV with high protein recovery compared to previous reports. For 5-15 mg/ml plasma IgG run to 100 L/m , similar filtration behavior was achieved for flux of 10-100 LMH, and lower flux runs remained well below the maximum operating pressure, suggesting that higher throughput in continuous processing is achievable. Comparison of fit of plasma IgG and mAb filtration behavior to four blocking models showed little differences but slightly better fit to the cake filtration model. Viral clearance of the filtration step tested by in-line spiking X-MuLV or MVM into purified plasma IgG following the chromatography step showed robust removal at low flux. Integrating the Planova BioEX filter into continuous processes with column chromatography can achieve efficient downstream processing with reduced footprint and process time.

摘要

我们评估了在集成工艺中直接在流穿柱层析后,单克隆抗体 (mAb) 和血浆 IgG 在恒流率下的过滤行为和病毒去除能力。在串联混合模式 AEX 和改良 CEX 柱上以流穿模式处理定量宿主细胞蛋白 (HCP) 含量的 mAb 溶液,连接到 Planova BioEX 过滤器(无池),实现了 HCP 对数减少值 (LRV) 为 2.3 和 93.9%的蛋白质回收率,与之前的报告相比,显示出可比或更高的 HCP LRV 与高蛋白质回收率。对于 5-15mg/ml 的血浆 IgG 运行至 100L/m,通量为 10-100LMH 时实现了类似的过滤行为,而较低通量的运行仍远低于最大操作压力,表明连续处理中可以实现更高的通量。将血浆 IgG 和 mAb 过滤行为拟合到四个阻塞模型的比较表明,差异很小,但与蛋糕过滤模型的拟合更好。在层析步骤后通过在线掺入 X-MuLV 或 MVM 对纯化的血浆 IgG 进行过滤步骤的病毒清除测试显示,在低通量下具有强大的去除能力。将 Planova BioEX 过滤器集成到带有柱层析的连续工艺中,可以实现具有减小占地面积和缩短工艺时间的高效下游处理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a595/8453883/ab7a2fa70d05/BIT-118-3569-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a595/8453883/d0eba0004574/BIT-118-3569-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a595/8453883/e3656090f187/BIT-118-3569-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a595/8453883/316537af0676/BIT-118-3569-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a595/8453883/36d3865ddbf5/BIT-118-3569-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a595/8453883/6289a89f590b/BIT-118-3569-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a595/8453883/9189cf7466b4/BIT-118-3569-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a595/8453883/1ace3ed01235/BIT-118-3569-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a595/8453883/ab7a2fa70d05/BIT-118-3569-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a595/8453883/d0eba0004574/BIT-118-3569-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a595/8453883/e3656090f187/BIT-118-3569-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a595/8453883/316537af0676/BIT-118-3569-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a595/8453883/36d3865ddbf5/BIT-118-3569-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a595/8453883/6289a89f590b/BIT-118-3569-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a595/8453883/9189cf7466b4/BIT-118-3569-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a595/8453883/1ace3ed01235/BIT-118-3569-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a595/8453883/ab7a2fa70d05/BIT-118-3569-g006.jpg

相似文献

1
Analysis of filtration behavior using integrated column chromatography followed by virus filtration.采用整体柱色谱法结合病毒过滤法分析过滤行为。
Biotechnol Bioeng. 2021 Sep;118(9):3569-3580. doi: 10.1002/bit.27840. Epub 2021 Jun 8.
2
Limits in virus filtration capability? Impact of virus quality and spike level on virus removal with xenotropic murine leukemia virus.病毒过滤能力的限制?病毒质量和加标水平对异嗜性小鼠白血病病毒去除的影响。
Biotechnol Prog. 2015 Jan-Feb;31(1):135-44. doi: 10.1002/btpr.2020. Epub 2014 Nov 29.
3
Viral clearance in end-to-end integrated continuous process for mAb purification: Total flow-through integrated polishing on two columns connected to virus filtration.单克隆抗体纯化的端到端集成连续工艺中的病毒清除:在连接到病毒过滤的两根柱子上进行全流通集成精制。
Biotechnol Bioeng. 2023 Oct;120(10):2977-2988. doi: 10.1002/bit.28464. Epub 2023 Jun 8.
4
Adapting virus filtration to continuous processing: Effects of product and process variability on filtration performance.适应病毒过滤的连续处理:产品和工艺变异性对过滤性能的影响。
Biotechnol Prog. 2024 Mar-Apr;40(2):e3407. doi: 10.1002/btpr.3407. Epub 2023 Dec 25.
5
Validation and implementation of Planova™ BioEX virus filters in the manufacture of a new liquid intravenous immunoglobulin in China.Planova™ BioEX病毒过滤器在中国一种新型液体静脉注射免疫球蛋白生产中的验证与应用
Biologicals. 2018 Mar;52:37-43. doi: 10.1016/j.biologicals.2018.01.004. Epub 2018 Feb 9.
6
Effect of pH, NaCl concentration, and mAb concentration of feed solution on the filterability of Planova™ 20N and Planova™ BioEX.pH 值、NaCl 浓度和进料溶液中单抗浓度对 Planova™ 20N 和 Planova™ BioEX 过滤性能的影响。
Biotechnol Prog. 2024 Mar-Apr;40(2):e3420. doi: 10.1002/btpr.3420. Epub 2023 Dec 25.
7
Characterizing the impact of pressure on virus filtration processes and establishing design spaces to ensure effective parvovirus removal.表征压力对病毒过滤过程的影响并建立设计空间以确保有效去除细小病毒。
Biotechnol Prog. 2017 Sep;33(5):1294-1302. doi: 10.1002/btpr.2506. Epub 2017 Jun 21.
8
Investigating the combination of single-pass tangential flow filtration and anion exchange chromatography for intensified mAb polishing.研究单通道切向流过滤与阴离子交换色谱联用在单抗强化精制中的应用。
Biotechnol Prog. 2019 Sep;35(5):e2862. doi: 10.1002/btpr.2862. Epub 2019 Jun 19.
9
Using a noninfectious MVM surrogate for assessing viral clearance during downstream process development.使用非感染性 MVM 替代物评估下游工艺开发过程中的病毒清除情况。
Biotechnol Prog. 2020 Jan;36(1):e2921. doi: 10.1002/btpr.2921. Epub 2019 Oct 14.
10
Adapting virus filtration to enable intensified and continuous monoclonal antibody processing.调整病毒过滤以实现单克隆抗体的强化和连续处理。
Biotechnol Prog. 2021 Mar;37(2):e3088. doi: 10.1002/btpr.3088. Epub 2020 Dec 11.

引用本文的文献

1
Modeling virus filtration: Materials, applications, and mechanism.病毒过滤建模:材料、应用及机制
iScience. 2024 Dec 4;28(1):111533. doi: 10.1016/j.isci.2024.111533. eCollection 2025 Jan 17.
2
Integration of a perfusion reactor and continuous precipitation in an entirely membrane-based process for antibody capture.在一个完全基于膜的过程中,将灌注反应器与连续沉淀相结合用于抗体捕获。
Eng Life Sci. 2023 Sep 7;23(10):e2300219. doi: 10.1002/elsc.202300219. eCollection 2023 Oct.

本文引用的文献

1
Polishing approach with fully connected flow-through purification for therapeutic monoclonal antibody.用于治疗性单克隆抗体的具有全连接流通式纯化的抛光方法。
Eng Life Sci. 2018 Oct 24;19(1):31-36. doi: 10.1002/elsc.201800123. eCollection 2019 Jan.
2
Development of small-scale models to understand the impact of continuous downstream bioprocessing on integrated virus filtration.开发小规模模型以了解连续下游生物处理对集成病毒过滤的影响。
Biotechnol Prog. 2020 May;36(3):e2962. doi: 10.1002/btpr.2962. Epub 2020 Feb 3.
3
Side-by-side comparability of batch and continuous downstream for the production of monoclonal antibodies.
单克隆抗体生产中批处理和连续下游工艺的并排可比性。
Biotechnol Bioeng. 2020 Apr;117(4):1024-1036. doi: 10.1002/bit.27267. Epub 2020 Jan 29.
4
Trends in Upstream and Downstream Process Development for Antibody Manufacturing.抗体制造上下游工艺开发的趋势
Bioengineering (Basel). 2014 Oct 1;1(4):188-212. doi: 10.3390/bioengineering1040188.
5
White Paper on Continuous Bioprocessing May 20-21 2014 Continuous Manufacturing Symposium.《连续生物加工白皮书》2014年5月20 - 21日连续制造研讨会
J Pharm Sci. 2015 Mar;104(3):813-820. doi: 10.1002/jps.24268. Epub 2016 Jan 8.
6
Mechanistic modeling of the loss of protein sieving due to internal and external fouling of microfilters.微滤器内部和外部污垢导致蛋白质筛分损失的机理建模。
Biotechnol Prog. 2017 Sep;33(5):1323-1333. doi: 10.1002/btpr.2514. Epub 2017 Jul 21.
7
Characterizing the impact of pressure on virus filtration processes and establishing design spaces to ensure effective parvovirus removal.表征压力对病毒过滤过程的影响并建立设计空间以确保有效去除细小病毒。
Biotechnol Prog. 2017 Sep;33(5):1294-1302. doi: 10.1002/btpr.2506. Epub 2017 Jun 21.
8
Use of MMV as a Single Worst-Case Model Virus in Viral Filter Validation Studies.在病毒过滤器验证研究中使用MMV作为单一最坏情况模型病毒。
PDA J Pharm Sci Technol. 2014 May-Jun;68(3):297-311. doi: 10.5731/pdajpst.2014.00978.
9
Viral clearance by flow-through mode ion exchange columns and membrane adsorbers.采用流通过模式离子交换柱和膜吸附器清除病毒。
Biotechnol Prog. 2014 Jan-Feb;30(1):124-31. doi: 10.1002/btpr.1832. Epub 2013 Nov 18.
10
Fed-batch and perfusion culture processes: economic, environmental, and operational feasibility under uncertainty.分批补料和灌注培养工艺:不确定性下的经济、环境和运行可行性。
Biotechnol Bioeng. 2013 Jan;110(1):206-19. doi: 10.1002/bit.24608. Epub 2012 Aug 6.